MedPath

MICHAEL Method- Fulfilling Individual Potential to Attain Excellence - as a Tool for Improving Metabolic Control and Quality of Life Among Adolescence With Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes
Interventions
Behavioral: Michael Method
Registration Number
NCT01691287
Lead Sponsor
Rabin Medical Center
Brief Summary

Type 1 diabetes is the most common childhood disease. Treatment of diabetes requires personal checks of blood sugar levels, injecting insulin, changing eating habits and physical exercise, which requires a real change in the life of the child \& adolescent and can cause significant damage to the quality of life as well.

Compliance to treatment is a major challenge for all patients and mostly to adolescence, which often worsen their diabetes control at that age.

The Michael Method is a unique, holistic program to develop and realize an individual's emotional, intellectual and behavioral potential, which is based on the belief that every human being can excel in every field they choose. The method was developed in 1988 by a multi-disciplinary team of professional academic in Israel. Today the Israeli education system implements the method in Junior High Schools and High Schools in diverse educational sectors. The program is taught at many other various frameworks: teachers' continuing education programs, colleges, programs run by the Ministries of Defense and Social Welfare, the National Insurance Institute, the National Electric Corporation and in many other public and private frameworks.

The proposed study is aimed to assess whether the Michael Method can be used as a tool for improving metabolic control and quality of life among uncontrolled adolescence with type 1 diabetes

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Type 1 Diabetes at least 1 year prior to study inclusion
  • 12-17 years old
  • HbA1c > 7.8%
Exclusion Criteria
  • Incapability to comply with all study requirements

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Michael MethodMichael Method14 group meeting, taking place once a week during 14 consecutive weeks
Primary Outcome Measures
NameTimeMethod
Metabolic Control measured as HbA1c levelat the end of the study - after 15 weeks
Secondary Outcome Measures
NameTimeMethod
Number of Diabetic Keto Acidosis eventsat the end of the study- after 15 weeks
Diabetes Quality of Life questionnaire (DQOLY)At the end of the study- after 15 weeks
Self assessment questionnaireAt the end of the study- after 15 weeks
Number of severe hypoglycemic eventsat the end of the study-after 15 weeks

Trial Locations

Locations (1)

Schneider Medical Center

🇮🇱

Petah-TTikva, Israel

© Copyright 2025. All Rights Reserved by MedPath